Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

A $2.88 Billion Reason Why Eli Lilly Stock Is in Focus Today

Eli Lilly (LLY) shares are in the spotlight on Monday after the pharmaceutical behemoth announced a $2.88 billion acquisition of Merida Biosciences. The all-cash acquisition of the biotechnology company marks LLY’s latest move to expand its drug pipeline.

Note that Eli Lilly stock has been a blockbuster investment in recent months, currently up roughly 35% versus its year-to-date low in late April.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.